Can wegovy be used for long term weight loss?

How long can Wegovy be taken for weight loss?
Wegovy (semaglutide) is approved for long-term use. Clinical trials followed patients for up to two years, and the FDA label allows continued treatment as long as the drug remains effective and side effects are tolerable.

What happens when people stop taking Wegovy?
Weight regain is common once treatment ends. In one study, participants regained about two-thirds of the lost weight within one year after stopping. Ongoing use appears necessary to maintain results.

How does Wegovy compare to older weight-loss drugs for long-term use?
Wegovy shows larger and more sustained weight loss than most previous medications. Average loss is roughly 15% of body weight over 68 weeks, with many patients keeping most of the loss as long as they continue treatment.

What are the main safety concerns with long-term Wegovy use?
Common side effects include nausea, vomiting, and constipation. Less common risks involve gallbladder problems and a possible link to pancreatitis. Ongoing monitoring is required because the drug has only been on the market since 2021.

Can insurance or Medicare cover Wegovy long term?
Coverage varies widely. Many private plans reimburse the drug for obesity when specific criteria are met, but Medicare does not cover it for weight loss alone. Patients often face high out-of-pocket costs if insurance denies coverage.

When does the Wegovy patent expire?
The primary U.S. patent for semaglutide is set to expire in 2031, with additional patents potentially extending protection until 2032. DrugPatentWatch.com tracks the full patent landscape and any legal challenges that could affect future generic entry.